Engineering Technologies and Clinical Translation
eBook - ePub

Engineering Technologies and Clinical Translation

Volume 3 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy

  1. 524 pages
  2. English
  3. ePUB (mobile friendly)
  4. Only available on web
eBook - ePub

Engineering Technologies and Clinical Translation

Volume 3 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy

Book details
Table of contents
Citations

About This Book

Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy examines the challenges of delivering immuno-oncology therapies, focusing specifically on the development of solutions for drug delivery and its clinical outcomes. Immuno-oncology (IO) is a growing field of medicine at the interface of immunology and cancer biology leading to development of novel therapeutic approaches, such as chimeric antigen receptor T-cell (CAR-T) and immune checkpoint blockade antibodies, that are clinically approved approaches for cancer therapy. Although currently approved IO approaches have shown tremendous promise for select types of cancers, broad application of IO strategies could even further improve the clinical success, especially for diseases such as pancreatic cancer, brain tumors where the success of IO so far has been limited. This volume of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy discusses biomaterial, microfluidic, and biodegradable devices, engineered microbes, personalized medicine, clinical approval process, and many other IO technologies.

Engineering Technologies and Clinical Translation: Volume 3: Delivery Strategies and Engineering Technologies in Cancer Immunotherapy creates a comprehensive treaty that engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side.

  • Explores engineering technologies and their clinical translation in a comprehensive way
  • Presents forecasting on the future of nanotechnology and drug delivery for IO
  • Engages the scientific and medical community who are involved in the challenges of immunology, cancer biology, and therapeutics with possible solutions from the nanotechnology and drug delivery side

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Engineering Technologies and Clinical Translation by Mansoor M. Amiji,Lara Scheherazade Milane in PDF and/or ePUB format, as well as other popular books in Biological Sciences & Biotechnology. We have over one million books available in our catalogue for you to explore.

Information

Year
2021
ISBN
9780323909501

Table of contents

  1. Cover image
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contributors
  7. Preface
  8. Acknowledgments
  9. Chapter One: Engineering solutions to design CAR-T cells
  10. Chapter Two: Engineered microbes for cancer immunotherapy
  11. Chapter Three: Polymeric scaffolds for antitumor immune cell priming
  12. Chapter Four: Biomaterials and devices for immunotherapy
  13. Chapter Five: Engineered devices for tumor microenvironment immune modulation
  14. Chapter Six: Tumor-on-a-chip devices for cancer immunotherapy
  15. Chapter Seven: Challenges and opportunities of nanotechnology in cancer immunotherapy
  16. Chapter Eight: Stromal modulation strategies to improve immunotherapy response in cancer
  17. Chapter Nine: Spatial mapping of the tumor immune microenvironment
  18. Chapter Ten: Nucleic acid biomarker technology for cancer immunotherapy
  19. Chapter Eleven: Proteomic biomarker technology for cancer immunotherapy
  20. Chapter Twelve: Personalized cancer immunotherapy
  21. Chapter Thirteen: Image-guided cancer immunotherapy
  22. Chapter Fourteen: Clinical translation and challenges in cancer immunotherapies
  23. Index